A multimodal cancer rehabilitation programme for women treated for female reproductive cancers: a pilot study

INTERVENTION: Each participant will be randomly assigned either to an intervention group or a control group in 1:1 ratio using block randomisation. Participants in the intervention group will receive a 12‐week multimodal cancer rehabilitation intervention, in which they will be granted access to a culturally adapted version of WWACP (WWACPHK) developed by our research team via a web or mobile‐enabled platform. The 12‐ week programme will cover topics such as healthy diet, exercise, menopause‐related symptoms and management, sleep, sexuality, body image, pelvic floor exercises, stress management, chronic disease prevention and cancer screening; new information and evidence will be posted on the website/app every day in the first three weeks, and then weekly for the following nine weeks. A research nurse will monitor participants’ page views and the number of modules accessed, and conduct reminder telephone calls when an account is inactive for a week or more to enhance adherence. Furthermore, three individual virtual counselling sessions with the research nurse will be scheduled at weeks 1, 6 and 12 to (i) empower the participants by providing guidance on the use of the digital platform and the needed health information; and (ii) engaging the participants to reflect on their belief, assumptions, knowledge and goals. Participants in the control group will receive brief information on the follow‐up schedule during baseline data collection. To control for the attention effect, participants will receive attention from the research nurse on three occasions in the same period of time as the intervention group. The nurse will make telephone calls to them at weeks 1, 6 and 12 to deliver general greetings and will not provide any kind of inter CONDITION: Women treated for female reproductive cancers (breast, uterine, ovarian or cervical cancers) ; Cancer ; Malignant neoplasm of breast, Malignant neoplasm of uterus, part unspecified, Malignant neoplasm of ovary, Malignant neoplasm of cervix uteri PRIMARY OUTCOME: Sense of coherence measured using the Chinese version of the Sense of Coherence 13‐item Scale (CSOC‐13) at baseline, completion of the intervention, and 12 weeks after completion SECONDARY OUTCOME: ; 1. Cancer‐specific distress measured using the Chinese version of Impact of Events‐Revised scale (CIES‐R) ) at baseline, completion of the intervention, and 12 weeks after completion; 2. Health‐related quality of life measured using the Chinese version of the MOS 36‐item Short Form (SF‐36) Health Survey at baseline, completion of the intervention, and 12 weeks after completion; 3. Participants' experiences, perceptions and opinions explored by semi‐structured interviews upon completion of the intervention; INCLUSION CRITERIA: 1. Women with a primary diagnosis of female reproductive cancers (breast, uterine, ovarian or cervical cancers) 2. Within 3 months of completion of intensive cancer treatments (e.g. surgery, radiotherapy, and/or chemotherapy) but can be on maintenance therapies such as tamoxifen, trastuzumab and bisphosphonates 3. Over 18 years old 4. Able to understand spoken Cantonese and to read Chinese 5. Have internet‐connected computing devices or smartphones